ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
2,1,Plasma cell myeloma,Plasma cell myelomas,Plasma cell neoplasms,Neopl,N
3,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
3,2,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
4,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
5,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
6,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
7,1,Vasospasm,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
8,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
10,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
11,1,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
12,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
13,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
14,1,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
15,1,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,Y
16,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
17,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
17,2,Myeloid leukaemia,Leukaemias myeloid NEC,Leukaemias,Neopl,Y
17,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
17,4,Sideroblastic anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
17,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
18,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
19,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
19,2,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
19,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
19,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
20,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
21,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
22,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
22,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
23,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
24,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
25,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
25,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
25,3,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
25,4,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
25,5,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
26,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
27,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
28,1,Acute myeloid leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,N
29,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
30,1,Scleroderma,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,Y
31,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
32,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
33,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
33,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
33,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
34,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
34,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
35,1,Myeloid leukaemia,Leukaemias myeloid NEC,Leukaemias,Neopl,Y
36,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
36,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
36,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
37,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
38,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
38,2,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
39,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
39,2,Leukaemia,Leukaemias NEC,Leukaemias,Neopl,N
40,1,Myeloid leukaemia,Leukaemias myeloid NEC,Leukaemias,Neopl,N
41,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
41,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
41,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
41,4,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
42,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
43,1,Hypersensitivity pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
44,1,Hypersensitivity pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
45,1,Deafness,Hearing losses,Hearing disorders,Ear,N
46,1,Myeloid leukaemia,Leukaemias myeloid NEC,Leukaemias,Neopl,Y
47,1,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
48,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
49,1,Myeloproliferative neoplasm,Myeloproliferative disorders (excl leukaemias),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
50,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
51,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
52,1,Toxic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
53,1,Acute lymphocytic leukaemia recurrent,Leukaemias acute lymphocytic,Leukaemias,Neopl,Y
53,2,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
53,3,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
54,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
54,2,Toxic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
55,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
56,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
57,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
57,2,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
58,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
58,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
58,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
58,4,Stem cell transplant,Haematological therapeutic procedures NEC,Haematological and lymphoid tissue therapeutic procedures,Surg,N
59,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
59,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
59,3,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
60,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
60,2,Toxic encephalopathy,Encephalopathies toxic and metabolic,Encephalopathies,Nerv,N
61,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
61,2,Adenoviral hepatitis,Adenoviral infections,Viral infectious disorders,Infec,Y
61,3,Evans syndrome,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
62,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
62,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
63,1,Cerebral aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,N
64,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
65,1,Fontanelle bulging,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
65,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
66,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
67,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
67,2,Venoocclusive liver disease,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
68,1,Hypertonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
68,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
68,3,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
69,1,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
69,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
70,1,Perineal ulceration,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
70,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
71,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
72,1,Cystitis haemorrhagic,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
72,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
73,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,Y
73,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
73,3,Klebsiella infection,Klebsiella infections,Bacterial infectious disorders,Infec,N
74,1,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
74,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
75,1,Bronchitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
75,2,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
75,3,Microangiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
75,4,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
76,1,Bronchitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
76,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
77,1,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
77,2,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
77,3,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
78,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
78,2,Bronchitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
78,3,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
79,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
79,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
79,3,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
80,1,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
81,1,Blood stem cell transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
81,2,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,Y
82,1,Blood stem cell transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
83,1,Blood stem cell transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
84,1,Blood stem cell transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
85,1,Acute graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
85,2,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
85,3,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
85,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
86,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
87,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
87,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
87,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
87,4,Streptococcal bacteraemia,Streptococcal infections,Bacterial infectious disorders,Infec,N
87,5,Viral test positive,Virus identification and serology,Microbiology and serology investigations,Inv,N
88,1,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
88,2,Chronic kidney disease,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
88,3,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
88,4,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
88,5,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
88,6,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
89,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
89,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
89,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
89,4,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
89,5,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
89,6,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
89,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
90,1,Acute graft versus host disease in intestine,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
90,2,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
90,3,Chronic graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
90,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
91,1,Ewing's sarcoma,Bone sarcomas,Skeletal neoplasms malignant and unspecified,Neopl,N
91,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
92,1,B precursor type acute leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,Y
92,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
93,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
93,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
93,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
93,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
93,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
93,6,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
93,7,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
94,1,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
95,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
95,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
95,3,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
95,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
95,5,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
95,6,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
95,7,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
95,8,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
95,9,Venoocclusive disease,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
95,10,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
96,1,Meningitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
96,2,Streptococcal bacteraemia,Streptococcal infections,Bacterial infectious disorders,Infec,N
97,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
97,2,Dysbiosis,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
97,3,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
97,4,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
97,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
98,1,B precursor type acute leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
98,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
98,3,Philadelphia positive acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
99,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
99,2,Philadelphia positive acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,Y
100,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
100,2,Juvenile chronic myelomonocytic leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,Y
100,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
101,1,Ewing's sarcoma,Bone sarcomas,Skeletal neoplasms malignant and unspecified,Neopl,N
101,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
102,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
102,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
102,3,Gastroenteritis norovirus,Caliciviral infections,Viral infectious disorders,Infec,N
102,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
102,5,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
102,6,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
102,7,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
102,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
102,9,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
102,10,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
102,11,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
102,12,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
102,13,Vaccination site inflammation,Vaccination site reactions,Administration site reactions,Genrl,N
103,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
103,2,Guillain-Barre syndrome,Acute polyneuropathies,Peripheral neuropathies,Nerv,N
103,3,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
103,4,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
103,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
103,6,Varicella zoster virus infection,Herpes viral infections,Viral infectious disorders,Infec,N
104,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
104,2,BK virus infection,Polyomavirus infections,Viral infectious disorders,Infec,N
104,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
104,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
104,5,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
104,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
104,7,Viral haemorrhagic cystitis,Viral infections NEC,Viral infectious disorders,Infec,N
105,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
105,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
105,3,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
105,4,Serum amyloid A protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
106,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
106,2,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
106,3,Cardiac failure acute,Heart failures NEC,Heart failures,Card,N
106,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
106,5,Inspiratory capacity decreased,Respiratory and pulmonary function diagnostic procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
106,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
106,7,Rales,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
107,1,Mycobacterium abscessus infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
107,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
107,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
107,4,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
107,5,Stenotrophomonas infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
108,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
108,2,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
108,3,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
109,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
109,2,Mycobacterium abscessus infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
109,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
109,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
110,1,Coronavirus infection,Coronavirus infections,Viral infectious disorders,Infec,N
110,2,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
110,3,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
110,4,Mycobacterium abscessus infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
110,5,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
110,6,Stenotrophomonas infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
110,7,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
111,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
111,2,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
111,3,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
111,4,Engraftment syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
111,5,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
111,6,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
111,7,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
111,8,Posterior reversible encephalopathy syndrome,Encephalopathies NEC,Encephalopathies,Nerv,N
112,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
113,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
113,2,Fungal infection,Fungal infections NEC,Fungal infectious disorders,Infec,N
113,3,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
114,1,Mycobacterium abscessus infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
114,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
114,3,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
114,4,Respiratory syncytial virus infection,Respiratory syncytial viral infections,Viral infectious disorders,Infec,N
114,5,Stenotrophomonas infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
115,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
115,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
115,3,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
115,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
115,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
115,6,Pneumonia viral,Viral infections NEC,Viral infectious disorders,Infec,N
115,7,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,Y
116,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
116,2,Immune reconstitution inflammatory syndrome,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
116,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
116,4,Staphylococcal bacteraemia,Staphylococcal infections,Bacterial infectious disorders,Infec,N
117,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
117,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
117,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
118,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
118,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
118,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
119,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
119,2,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
119,3,Micrococcal sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
119,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
120,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
120,2,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
120,3,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
120,4,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
120,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
120,6,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,Y
120,7,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
121,1,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
121,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
121,3,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
121,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
121,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
122,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
122,2,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
123,1,Pseudostroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
124,1,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
124,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
124,3,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
124,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
124,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
124,6,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
124,7,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
125,1,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
125,2,Capillary leak syndrome,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
125,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
125,4,Graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
125,5,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
125,6,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
125,7,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
125,8,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
125,9,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
125,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
125,11,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
125,12,Thrombotic microangiopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,Y
125,13,Viraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
126,1,Cytomegalovirus viraemia,Cytomegaloviral infections,Viral infectious disorders,Infec,N
126,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
126,3,Pneumonia viral,Viral infections NEC,Viral infectious disorders,Infec,N
126,4,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
126,5,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,Y
127,1,Pneumonia cytomegaloviral,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
128,1,Mycobacterial infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
128,2,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
129,1,Bacteraemia,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
129,2,Mycobacterium chelonae infection,Atypical mycobacterial infections,Mycobacterial infectious disorders,Infec,N
129,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
129,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
129,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
129,6,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
130,1,Graft versus host disease in gastrointestinal tract,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
131,1,Acute graft versus host disease in skin,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
132,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
133,1,Congenital aplasia,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
133,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
133,3,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
134,1,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
134,2,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
135,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
135,2,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
135,3,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
136,1,Cytomegalovirus infection,Cytomegaloviral infections,Viral infectious disorders,Infec,N
137,1,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
138,1,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
138,2,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
138,3,Parvovirus infection,Parvoviral infections,Viral infectious disorders,Infec,N
139,1,Human herpesvirus 6 infection,Herpes viral infections,Viral infectious disorders,Infec,N
140,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
140,2,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
140,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
140,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
140,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
